Identification of potential genomic biomarkers for Parkinson's disease using data pooling of gene expression microarrays

Biomark Med. 2021 Jun;15(8):585-595. doi: 10.2217/bmm-2020-0325. Epub 2021 May 14.

Abstract

Aim: In this study, we aimed to identify potential diagnostic biomarkers Parkinson's disease (PD) by exploring microarray gene expression data of PD patients. Materials & methods: Differentially expressed genes associated with PD were screened from the GSE99039 dataset using weighted gene co-expression network analysis, followed by gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses, gene-gene interaction network analysis and receiver operator characteristics analysis. Results: We identified two PD-associated modules, in which genes from the chemokine signaling pathway were primarily enriched. In particular, CS, PRKCD, RHOG and VAMP2 directly interacted with known PD-associated genes and showed higher expression in the PD samples, and may thus be potential biomarkers in PD diagnosis. Conclusion: A DFG-analysis identified a four-gene panel (CS, PRKCD, RHOG, VAMP2) as a potential diagnostic predictor to diagnose PD.

Keywords: CS; PRKCD; Parkinson’s disease; RHOG; ROC; VAMP2; diagnostic biomarkers; weighted gene co-expression network analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / analysis*
  • Case-Control Studies
  • Gene Expression Profiling
  • Gene Ontology*
  • Gene Regulatory Networks*
  • Genomics / methods*
  • Humans
  • Parkinson Disease / genetics*
  • Parkinson Disease / pathology*
  • Protein Interaction Maps*
  • Signal Transduction

Substances

  • Biomarkers